Miriam Rica
CEO

The startup develops nebulizers that deliver medication through inhalation for patients with asthma, cystic fibrosis, and other respiratory conditions. Their devices minimize medication errors and eliminate the need for cleaning, enhancing treatment adherence and patient quality of life.
Raised to date
$300KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
